Personal profile
Fingerprint
Dive into the research topics where Gordon McGregor is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
MErCuRIC1: A Phase Ia study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor crizotinib in patients with advanced solid tumours
Woodcock, V., Middleton, M., Rolfo, C., Elez, E., Van Schaeybroeck, S., Taieb, J., Houlden, J., Collins, L., Love, S., Roberts, C., Andre, T., Jones, R., Lawler, M., Di Nicolantonio, F., Grayson, M., Bardelli, A., Laurent=puig, P., McGregor, G., Maughan, T. & Tabernero, J. & 2 others, , 11 Oct 2016, MErCuRIC1: A Phase Ia study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor crizotinib in patients with advanced solid tumours. National Cancer Research InstituteResearch output: Chapter in Book/Report/Conference proceeding › Conference contribution
-
Detection of cathepsin S cysteine protease in human brain tumour microdialysates in vivo.
Flannery, T., McConnell, R. S., McQuaid, S., McGregor, G., Mirakhur, M., Martin, L., Scott, C., Burden, R., Walker, B., McGoohan, C. & Johnston, P., Apr 2007, In: British Journal of Neurosurgery. 21, 2, p. 204-209 6 p.Research output: Contribution to journal › Article › peer-review
22 Link opens in a new tab Citations (Scopus) -
Cathepsin S expression: An independent prognostic factor in glioblastoma tumours - A pilot Study
Scott, C., Flannery, T., McQuaid, S., McGoohan, C., McConnell, R. S., McGregor, G., Mirakhur, M., Hamilton, P., Diamond, J., Cran, G., Walker, B., Martin, L., Ellison, D., Patel, C., Nicholson, C., Mendelow, D., McCormick, D. & Johnston, P., 15 Aug 2006, In: International Journal of Cancer. 119, 4, p. 854-860 7 p.Research output: Contribution to journal › Article › peer-review
82 Link opens in a new tab Citations (Scopus)